Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06431685
- Conditions
- Central Nervous System Neoplasms, Leptomeningeal Metastasis, Low Dose Radiotherapy, +8 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
NCT07312422
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
NCT07233252
- Conditions
- Kidney-sparing, Nab-paclitaxel, PD-1 Inhibitor, +2 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China
NCT07126119
- Conditions
- Nab-paclitaxel, Neoadjuvant Therapy, PD-1 Inhibitor, +1 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China
Recruiting
Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer
NCT07125547
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney-sparing, +14 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China
NCT06811844
- Conditions
- Chemotherapy, Complete Response, Disease Attributes, +16 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
- Zhangzhou Affiliated Hospital of Fujian Medical University Zhangzhou, Fujian, China
- Hainan General Hospital Haikou, Hainan, China
Recruiting
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
NCT06333561
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Chinese PLA General hospital Beijing, Beijing Municipality, China
NCT06006650
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Chemotherapy, +15 more
- Locations
-
- Tangdu Hospital of the Fourth Millitary Medical University Xi'an, Shaanxi, China
- Hongtao Duan Xi’an, Shanxi, China
- Tangdu Hospital, the Air Force Military University Xi'an, China
NCT05392413
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Nanfang Hospital Guangzhou, China
NCT05290194
- Conditions
- Capecitabine, Carcinoma, Head and Neck Neoplasms, +14 more
- Locations
-
- Fifth Affilliated Hospital of Sun Yat-sen University Zhuhai, Guangdong, China
NCT07686796
- Conditions
- Capecitabine, Local Advanced Rectal Cancer, Oxaliplatin, +4 more
- Locations
-
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
Not Yet Recruiting
Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2
NCT07531979
- Conditions
- Becotatug Vedotin, Chemotherapy, EGFR ADC, +3 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
Not Yet Recruiting
Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer
NCT07394192
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
- Locations
-
Not specified
Not Yet Recruiting
Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders.
NCT07133763
- Conditions
- Chidamide, EBV-Associated Lymphoproliferative Disorders, Lenalidomide, +2 more
- Locations
-
Not specified
Not Yet Recruiting
Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.
NCT07133776
- Conditions
- Chidamide, DNA Virus Infections, Epstein-Barr Virus (EBV) Infection, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer
NCT06871527
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Fruquintinib, +11 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Active, Not Recruiting
Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis
NCT06809530
- Conditions
- CTLA4, Central Nervous System Neoplasms, Leptomeningeal Metastasis, +9 more
- Locations
-
- Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine Beijing, Beijing Municipality, China
- The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
- Huizhou First Hospital Affiliated to Guangdong Medical University Huizhou, Guangdong, China
- Beijing Chest Hospital, Capital Medical University Beijing, China
Active, Not Recruiting
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
NCT05615142
- Conditions
- Low Dose Radiotherapy, NSCLC, PD-1 Inhibitor, +1 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
Active, Not Recruiting
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer
NCT06865521
- Conditions
- Akkermansia Muciniphila, Colo-rectal Cancer, Colonic Diseases, +11 more
- Locations
-
- Colorectal Cancer, West China Hospital Chengdu, Sichuan, China
- Colorectal Cancer, West China Hospital Chengdu, Sichuan, China
Active, Not Recruiting
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05340270
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +13 more
- Locations
-
- The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China